Encare Spermicide Safety During Pregnancy: What You Need to Know

Encare (nonoxynol-9 vaginal suppository) is a spermicidal contraceptive. Its safety profile in established pregnancy is reassuring but comes with caveats.

Key Facts

  • Active ingredient: Nonoxynol-9 (N-9), a surfactant that disrupts sperm membranes
  • Pregnancy category: Not formally assigned (pre-1979); no teratogenicity in animal studies at clinical doses
  • Systemic absorption: Minimal (<3% vaginal absorption); negligible fetal exposure
  • Teratogenicity: No human or animal evidence of structural anomalies
  • Miscarriage risk: No epidemiological association

Risks and Considerations

  • Genital irritation: N-9 damages vaginal epithelium → increased HIV/STI susceptibility if exposed
  • Contraceptive failure: Typical use failure rate ~21%; if pregnancy occurs, discontinue use
  • Not for established pregnancy: No contraceptive indication once pregnant
  • Microbiome disruption: May reduce lactobacilli → increased bacterial vaginosis/yeast risk

If You Used Encare Around Conception

  • No evidence of harm to embryo or fetus
  • Discontinue once pregnancy is confirmed
  • No need for extra testing or termination
  • Inform your OB for complete medication history

Better Contraception for the Future

  • IUD (hormonal or copper) — >99% effective
  • Implant — >99% effective
  • Combined hormonal (pill, patch, ring) — 91% typical use
  • Condoms + spermicide — 82% typical use (better than spermicide alone)

Always discuss contraceptive choices with your provider, especially if planning pregnancy.

Infertility - Related Articles